European Pharmaceutical Review

OCTOBER 19, 2023

How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? This has been demonstrated recently with PLUVICTO ® , which was the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer.

Chemotherapy 105

Chemotherapy Compounding Immunization FDA 105

PharmaShots

MARCH 29, 2023

Lupin has earned the US FDA approval for the generic version of Banzel as Rufinamide Oral Suspension. Company: Supernus Pharmaceuticals Generic Name: Topiramate First Approval Date: Aug 16, 2013 Patent Expiration: Jan 2023 2022 Sales: $261.2M The exact mechanism of action is uncertain.

FDA 49

FDA Chemotherapy Immunization Dosage 49

The Checkup by Singlecare

OCTOBER 16, 2023

Food and Drug Administration (FDA) in 2004 , Cymbalta has become a widely used antidepressant to treat various mental health and pain-related conditions. The patent for brand-name Cymbalta expired in 2013, allowing other companies to produce and market duloxetine, the Cymbalta generic name. Approved by the U.S.

Dosage 52

Dosage Insurance Coverage Labelling Insurance 52

The Checkup by Singlecare

DECEMBER 6, 2023

Furosemide, also known by its brand name Lasix, is approved by the United States Food and Drug Administration (FDA) and is available in several forms, including oral tablet, oral solution, and injection. Cisplatin Cisplatin is a chemotherapy drug used to treat certain types of cancers.

Chemotherapy 52

Chemotherapy FDA 52

The Checkup by Singlecare

OCTOBER 27, 2023

Sources Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives , British Medical Journal (2020) Oral contraceptive efficacy and antibiotic interaction: a myth debunked , Journal of the American Academy of Dermatology (2002) Treatment of pneumococcal meningitis with (..)

Adverse Reactions 52

Adverse Reactions Labelling Chemotherapy Communication 52

The Checkup by Singlecare

JANUARY 12, 2024

The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs) , Toxicology and applied pharmacology (2013). Cleveland Clinic (2023).

Mayo Clinic 52

Mayo Clinic Communication Chemotherapy Dosage 52

ISPE

MAY 10, 2023

47 (18 November 2013): 12359–63. Mexican Governor: Cancer Children Given Water Instead of Chemotherapy.” SPuMoNI is particularly timely because blockchain has been proposed to become “a new digital service infrastructure” for Europe. Angewandte Chemie International Edition in English 52, no. doi:10.1002/anie.201305429 30 June 2016.

Chemotherapy 52

Chemotherapy Documentation Dosage Communication 52